[1] Abu-Duhier F M,Javid J,Sughayer M A,et al. Clinical significance of circulatory miRNA-21 as an efficient non-invasive biomarker for the screening of lung cancer patients[J].Asian Pacific Journal of Cancer Prevention Apjcp,2018,19(9):2607-2611. [2] Zaporozhchenko I A,Morozkin E S,Ponomaryova A A,et al. Profiling of 179 miRNA expression in blood plasma of lung cancer patients and cancer-free individuals[J].Scientific Reports,2018,8(1):6348. [3] 彭丹丹,邓东,胡小丽,等.双源CT双能量成像标准化碘浓度与肺癌TNM分期的关系[J].放射学实践,2018,33(3):265-269. [4] Kontarakis Z,Rossi A,Ramas S,et al. miR-126 is a conserved modulator of lymphatic development[J].Developmental Biology,2018,437(2):120-130. [5] Liu X,Gao X,Zhang W,et al.MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway[J].IUBMB Life,2018,70(1):81-91. [6] 支修益,石远凯,于金明.中国原发性肺癌诊疗规范(2015年版)[J].中华肿瘤杂志,2015,37(1):67-78. [7] 中华医学会呼吸病学分会肺癌学组,中国肺癌防治联盟专家组.肺部结节诊治中国专家共识[J].中华结核和呼吸杂志,2015,38(4):249-254. [8] 陈小华,李佳音,李莉明,等.感兴趣区选择对胃癌能谱CT测量结果可重复性的影响及与微血管密度的关系[J].中华放射学杂志,2018,52(1):24-29. [9] 吴芳,杜祥颖,张苗,等.第三代双源CT早期鉴别诊断急性缺血性脑卒中患者血管内治疗后颅内出血灶与碘对比剂[J].中国医学影像技术,2018,34(5):770-774. [10] 周锦,汤泊,张银,等.非小细胞肺癌淋巴结转移与肿瘤原发灶最大径及18F-FDGPET/CT代谢参数的相关性[J].中国医学影像学杂志,2019,27(3):188-192. [11] Jia Z,Zhang Y,Xu Q,et al.miR-126 suppresses epithelial-to-mesenchymal transition and metastasis by targeting PI3K/AKT/Snail signaling of lung cancer cells[J].Oncology Letters,2018,15(5):7369-7375. [12] 张玉洁,王微微,商安全,等.非小细胞肺癌患者血清miR-22和miR-126的检测及其临床意义[J].中国肿瘤生物治疗杂志,2017,24(12):1403-1408. [13] 杨建华,郭晓娟,牛广旭,等.胃癌患者血清miR-7、miR-204表达及其与临床病理特征、预后的关系[J].山东医药,2019,59(34):74-77. [14] 许有忠,田作春,李才.MicroRNA-204在非小细胞肺癌患者组织中的表达及对癌细胞增殖和凋亡的影响[J].中国现代医学杂志,2018,28(4):57-61. |